Literature DB >> 14671817

[HIV positive patient with pancytopenia and massive splenomegaly].

H J Epple1, G Harms, M Notter, R Husack, M Zeitz, T Schneider.   

Abstract

A 30-year-old homosexual man presented with anemia and a several months history of recurrent fever, night sweats and weakness. His travel history included several stays in mediterranean countries during the recent years. Abdominal ultrasound showed massive splenomegaly, hepatomegaly and abdominal lymphadenopathy. A bone marrow aspirate revealed the presence of numerous Leishmania amastigotes, and bone marrow culture and polymerase chain reaction were also positive for Leishmania. In this case report epidemiological, immunological, diagnostic and therapeutic aspects of HIV-Leishmania coinfection are discussed with special emphasis on the impact of liposomal amphotericin B and highly active antiretroviral therapy on the treatment of HIV-leishmania-coinfection.

Entities:  

Mesh:

Year:  2003        PMID: 14671817     DOI: 10.1007/s00108-003-0980-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  12 in total

1.  Leishmania/HIV co-infection, south-western Europe, 1990-1998.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1999-11-05

2.  Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy.

Authors:  J Berenguer; J Cosín; P Miralles; J C López; B Padilla
Journal:  AIDS       Date:  2000-12-22       Impact factor: 4.177

Review 3.  [Leishmaniasis. Basic principles, clinical aspects, diagnosis and therapy].

Authors:  G Burbach; J May; G Harms; U Bienzle
Journal:  Dtsch Med Wochenschr       Date:  1999-01-29       Impact factor: 0.628

Review 4.  HIV-associated visceral leishmaniasis.

Authors:  V Pintado; R López-Vélez
Journal:  Clin Microbiol Infect       Date:  2001-06       Impact factor: 8.067

5.  Genetic heterogeneity in the species Leishmania tropica revealed by different PCR-based methods.

Authors:  G Schönian; L Schnur; M el Fari; L Oskam; A A Kolesnikov; W Sokolowska-Köhler; W Presber
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Mar-Apr       Impact factor: 2.184

Review 6.  Hematologic manifestations of the human immune deficiency virus (HIV).

Authors:  L I Zon; J E Groopman
Journal:  Semin Hematol       Date:  1988-07       Impact factor: 3.851

7.  Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome).

Authors:  R Russo; L C Nigro; S Minniti; A Montineri; L Gradoni; L Caldeira; R N Davidson
Journal:  J Infect       Date:  1996-03       Impact factor: 6.072

8.  Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral Leishmaniasis in immunocompromised patients.

Authors:  R Piarroux; F Gambarelli; H Dumon; M Fontes; S Dunan; C Mary; B Toga; M Quilici
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study.

Authors:  S Sundar; T K Jha; C P Thakur; M Mishra; V R Singh; R Buffels
Journal:  Am J Trop Med Hyg       Date:  2002-02       Impact factor: 2.345

10.  Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar.

Authors:  M Mishra; U K Biswas; A M Jha; A B Khan
Journal:  Lancet       Date:  1994-12-10       Impact factor: 79.321

View more
  1 in total

Review 1.  Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021-A Comprehensive Review.

Authors:  Rafael Rocha; André Pereira; Carla Maia
Journal:  Pathogens       Date:  2022-08-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.